Deep vein thrombosis prophylaxis: Better living through chemistry - In the affirmative

Journal of Arthroplasty

Volumn 20, Issue SUPPL. 2, 2005, Pages 12-14

  Kwong, Louis M ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Arthroplasty; Deep vein thrombosis; Prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FRACTURE REDUCTION; HUMAN; KNEE ARTHROPLASTY; META ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

EID: 24944512657     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2005.05.020     Document Type: Conference Paper

References (12)

1. W.H. Geerts, G.F. Pineo, and J.A. Heit Prevention of venous thromboembolism Chest 126 2004 338S 400S
2. A.S. Gallus Applying risk assessment models in orthopedic surgery: overview of our clinical experience Blood Coagul Fibrinolysis 10 Suppl 2 1999 S53
3. P. Prandoni, S. Villalta, and P. Bagatella The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients Haematologica 82 1997 423 428
4. R. Collins, A. Scrimgeour, and S. Yusuf Reduction in fatal pulmonary embolism and venous thrombosis by peri-operative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 318 1988 1162
5. W.H. Harris, E.W. Salzman, and C. Athansoulis Comparison of warfarin, low-molecular weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement J Bone Joint Surg Am 56 1974 1552
6. C.W. Colwell, D.K. Collis, and R. Paulson Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge J Bone Joint Surg Am 81 1999 932
7. R.D. Hull, and G.F. Pineo Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive? Semin Thromb Hemost 30 Suppl 1 2004 11
8. A.G.G. Turpie, K.A. Bauer, and B.I. Eriksson Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery: a meta-analysis of 4 randomized double-blind studies Arch Intern Med 162 2002 1833
9. W.H. Geerts, G.F. Pineo, and J.A. Heit Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl. 2004 338S
10. C. Patrono, B. Coller, and J.E. Dalen Platelet-active drugs: the relationship among dose, effectiveness, and side effects Chest 119 2001 39S
11. A.T. Cohen, J.A. Skinner, and V.V. Kakkar Antiplatelet treatment for thromboprophylaxis: a step forward or backwards? BMJ 309 1994 1213
12. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial Lancet 355 2000 1295